RNXT- Renovorx, Inc.

Name: Renovorx, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Renovorx, Inc. (RNXT) has 9 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. RNXT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Agah Ramtin	798.5K	$709.0K	-
Dir	Ryan Una S	47.6K	$42.3K	-
Dir	MacFarlane K. Angela	47.6K	$42.3K	-
Dir	Spiegel Robert J.	47.6K	$42.3K	-
VP	Kocak Ron	41.6K	$36.9K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 8, 2025	Marton Laurence	Director	Buy	12,050	$0.85	$10,218.40	+35.8%	+65.0%	+17.4%
Apr 7, 2025	Bagai Shaun77	Chief Executive Officer	Buy	10,000	$0.83	$8,300.00	+3.4%	+67.1%	+13.9%
Jan 26, 2024	Agah Ramtin76	Chief Medical Officer	Buy	40,983	$0.00	-	+632.7%	+15.2%	+31.4%
Jan 26, 2024	Bagai Shaun77	Chief Executive Officer	Buy	40,983	$0.00	-	+16.3%	+15.2%	+31.4%
Jan 26, 2024	MacFarlane K. Angela	Director	Buy	40,983	$0.00	-	New	+15.2%	+31.4%
Jan 26, 2024	Marton Laurence	Director	Buy	8,196	$0.00	-	+32.2%	+15.2%	+31.4%
Jan 26, 2024	Spiegel Robert J.	Director	Buy	40,983	$0.00	-	New	+15.2%	+31.4%
Oct 3, 2023	Nelms Angela	Chief Operating Officer	Buy	1,100	$1.05	$1,150.97	+366.7%	+88.6%	-4.3%
Jun 7, 2022	Agah Ramtin76	Chief Medical Officer	Buy	5,182	$1.93	$10,001.26	+400.2%	+18.5%	+1.5%
May 19, 2022	Bagai Shaun77	Chief Executive Officer	Buy	5,500	$2.05	$11,275.00	+2.2%	+35.3%	+16.8%

← PrevPage 3

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC